Immunogenicity 15696

summary
Sample ID
patient3
Response
Positive
Tumor Type
Melanoma
Gene Symbol
CARD16
Transcript ID
None
HLA INFO
B*27:05
TCR INFO

No TCR info found!

T cell Tumor cell B*27:05
sequence
Full length protein sequence (197 aa)
MADKV
1
LKEKR
6
KLFIH
11
SMGEG
16
TINGL
21
LDELL
26
QTRVL
31
NQEEM
36
EKVKR
41
ENATV
46
MDKTR
51
ALIDS
56
VIPKG
61
AQACQ
66
ICITY
71
ICEED
76
SYLAE
81
TLGLS
86
AALQA
91
VQDNP
96
AMPTC
101
SSPEG
106
RIKLC
111
FLEDA
116
QRIWK
121
QKLQR
126
CHVQN
131
TIIKW
136
SERYT
141
SGSFE
146
MQWLF
151
LRTNF
156
IERFW
161
RNILL
166
LPLHK
171
GSLYP
176
RIPGL
181
GKELQ
186
TGTHK
191
LS
196
Mutation Information
DNA mutation:
None
Peptide Range:
165 ~ 174
Mut AA position:
172 (8 in Wild Type peptide)
Alignment
Wild Type:
"WRNILLLPLH
|||||||.||
Mutant:
WRNILLLSLH"
reference

Nature, 2017

An immunogenic personal neoantigen vaccine for patients with melanoma

Gene Name (from Reference) CASP1

clinic trial
Checkpoint Blockade

None

ACT

N

Vaccination

Y

Curative Effect

no recurrence

experiment
minimal_peptide

Y

Antigen Type

peptide

T-cell Source

PBMCs

APC Type

APCs

Assay

None